Published in N Engl J Med on March 17, 1988
Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76
Transplantation of multiple abdominal viscera. JAMA (1989) 3.59
Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med (1993) 3.36
Interactions of allogeneic human mononuclear cells in the two-way mixed leucocyte culture (MLC): influence of cell numbers, subpopulations and cyclosporin. Clin Exp Immunol (1999) 0.97
Unsuccessful treatment of four patients with acute graft-vs-host disease after liver transplantation. World J Gastroenterol (2012) 0.89
Graft-versus-host disease after liver transplantation: a comprehensive literature review. World J Gastroenterol (2012) 0.88
Graft-versus-host disease after liver transplantation. Clinics (Sao Paulo) (2011) 0.87
New approaches in the use of cyclosporine: with particular reference to the liver. Transplant Proc (1988) 0.86
Graft Versus Host Disease After Liver Transplantation in Adults: A Case series, Review of Literature, and an Approach to Management. Transplantation (2016) 0.84
Acute graft versus host disease after orthotopic liver transplantation. J Hematol Oncol (2012) 0.83
A modified vascularized whole knee joint allotransplantation model in the rat. Microsurgery (2010) 0.83
Living bone allotransplants survive by surgical angiogenesis alone: development of a novel method of composite tissue allotransplantation. J Bone Joint Surg Am (2011) 0.83
Graft-versus-host disease after kidney transplantation. J Korean Surg Soc (2011) 0.79
Reversal of graft-versus-host disease with infusion of autologous bone marrow. Cell Transplant (1994) 0.79
Graft-versus-Host Disease after Living-Unrelated Kidney Transplantation. Case Rep Transplant (2014) 0.78
Reversal of Graft-Versus-Host Disease with Infusion of Stored Autologous Bone Marrow Cells Following Combined Liver-Bone Marrow Allotransplantation in Man. Transplant Sci (1993) 0.78
Comparison of potentiality to induce graft-versus-host reaction with small bowel, pancreas/spleen, and liver transplantation in the rat. Clin Exp Immunol (1993) 0.77
Graft-versus-host disease following liver transplantation. J R Soc Med (1992) 0.77
Absence of peripheral blood chimerism in graft-vs-host disease following orthotopic liver transplantation: case report and review of the literature. Int J Dermatol (2013) 0.76
Immunological basis for treatment of graft versus host disease after liver transplant. Expert Rev Clin Immunol (2016) 0.75
Successful salvage treatment of acute graft-versus-host disease after liver transplantation by withdrawal of immunosuppression: a case report. Korean J Hepatobiliary Pancreat Surg (2016) 0.75
The role of cell migration and microchimerism in the induction of tolerance after solid organ transplantation. Postgrad Med J (1997) 0.75
Correlation of Chimerism with Acute Graft-versus-Host Disease in Rats following Liver Transplantation. Int J Hepatol (2011) 0.75
Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature (1994) 10.22
The role of cell-mediated immunity in bacterial infections. Rev Infect Dis (1982) 9.26
Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg (1997) 8.86
Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem (1999) 8.16
One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. Ann Surg (1993) 5.87
Complications of iliac crest bone graft harvesting. Clin Orthop Relat Res (1996) 5.73
Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg (1995) 5.66
Double-masked randomized trial comparing alternate combinations of intraoperative anesthesia and postoperative analgesia in abdominal aortic surgery. Anesthesiology (2001) 5.54
Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg (1996) 5.42
A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy. Ann Surg (1995) 4.24
Importance of hospital volume in the overall management of pancreatic cancer. Ann Surg (1998) 4.19
Activation of gamma delta T cells in the primary immune response to Mycobacterium tuberculosis. Science (1989) 4.19
CD8+ T lymphocytes in intracellular microbial infections. Immunol Today (1988) 4.12
Protection of mice against the intracellular bacterium Listeria monocytogenes by recombinant immune interferon. Eur J Immunol (1984) 4.00
A recombinant 64 kilodalton protein of Mycobacterium bovis bacillus Calmette-Guerin specifically stimulates human T4 clones reactive to mycobacterial antigens. J Exp Med (1986) 3.92
Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. Ann Surg (1997) 3.90
Impaired resistance to Mycobacterium tuberculosis infection after selective in vivo depletion of L3T4+ and Lyt-2+ T cells. Infect Immun (1987) 3.87
Decreased morbidity and mortality after pancreatoduodenectomy. Am J Surg (1986) 3.81
Mycobacterial growth inhibition by interferon-gamma-activated bone marrow macrophages and differential susceptibility among strains of Mycobacterium tuberculosis. J Immunol (1987) 3.68
Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J Clin Invest (2000) 3.58
Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates. Infect Immun (1991) 3.54
Surgical rates and operative mortality for open and laparoscopic cholecystectomy in Maryland. N Engl J Med (1994) 3.53
Biological functions of t cell lines with specificity for the intracellular bacterium Listeria monocytogenes in vitro and in vivo. J Exp Med (1982) 3.52
Different roles of alpha beta and gamma delta T cells in immunity against an intracellular bacterial pathogen. Nature (1993) 3.47
Mycobacterial protein antigens: a compilation. Mol Microbiol (1992) 3.35
Activation of tuberculostatic macrophage functions by gamma interferon, interleukin-4, and tumor necrosis factor. Infect Immun (1990) 3.35
Specific Lyt 123 cells are involved in protection against Listeria monocytogenes and in delayed-type hypersensitivity to listerial antigens. J Exp Med (1979) 3.31
Does preoperative percutaneous biliary drainage reduce operative risk or increase hospital cost? Ann Surg (1985) 3.19
Erythromycin accelerates gastric emptying after pancreaticoduodenectomy. A prospective, randomized, placebo-controlled trial. Ann Surg (1993) 3.17
Career development for women in academic medicine: Multiple interventions in a department of medicine. JAMA (1996) 3.14
Pyogenic hepatic abscess. Changing trends over 42 years. Ann Surg (1996) 3.13
Distal pancreatectomy: indications and outcomes in 235 patients. Ann Surg (1999) 3.09
Immune response to infection with Salmonella typhimurium in mice. J Leukoc Biol (2000) 2.99
Salmonella typhimurium aroA- infection in gene-targeted immunodeficient mice: major role of CD4+ TCR-alpha beta cells and IFN-gamma in bacterial clearance independent of intracellular location. J Immunol (1996) 2.97
Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptotic execution. Proc Natl Acad Sci U S A (1995) 2.89
Mycobacteria-reactive Lyt-2+ T cell lines. Eur J Immunol (1988) 2.88
Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon gamma and tumor necrosis factor alpha. J Exp Med (1995) 2.80
T cells against a bacterial heat shock protein recognize stressed macrophages. Science (1989) 2.79
Assessment of aldehyde dehydrogenase in viable cells. Blood (1995) 2.77
Probable assignment of the Duffy blood group locus to chromosome 1 in man. Proc Natl Acad Sci U S A (1968) 2.74
Effective protection against Listeria monocytogenes and delayed-type hypersensitivity to listerial antigens depend on cooperation between specific L3T4+ and Lyt 2+ T cells. Infect Immun (1985) 2.70
Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide. Biol Blood Marrow Transplant (2002) 2.69
Role of heat shock proteins in protection from and pathogenesis of infectious diseases. Clin Microbiol Rev (1999) 2.69
Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med (1996) 2.63
Periampullary adenocarcinoma: analysis of 5-year survivors. Ann Surg (1998) 2.60
T- and B-lymphocyte-independent formation of alveolar macrophage-derived multinucleated giant cells in murine Pneumocystis carinii pneumonia. Infect Immun (1996) 2.55
Adenocarcinoma of the ampulla of Vater. A 28-year experience. Ann Surg (1997) 2.53
Postoperative bile duct strictures: management and outcome in the 1990s. Ann Surg (2000) 2.50
Computerised updating of clinical summaries: new opportunities for clinical practice and research? BMJ (1988) 2.49
Immune response to Mycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance. Eur J Immunol (1995) 2.48
The role of T-cell subsets and cytokines in the regulation of infection. Immunol Today (1991) 2.48
Immune responses to Yersinia enterocolitica in susceptible BALB/c and resistant C57BL/6 mice: an essential role for gamma interferon. Infect Immun (1994) 2.45
Enumeration of T cells reactive with Mycobacterium tuberculosis organisms and specific for the recombinant mycobacterial 64-kDa protein. Eur J Immunol (1987) 2.45
Listeria monocytogenes-reactive T lymphocyte clones with cytolytic activity against infected target cells. J Exp Med (1986) 2.42
Factors affecting mortality in biliary tract surgery. Am J Surg (1981) 2.41
Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjögren's syndrome. Arthritis Rheum (1986) 2.39
Studies with MHC-deficient knock-out mice reveal impact of both MHC I- and MHC II-dependent T cell responses on Listeria monocytogenes infection. J Immunol (1994) 2.39
A large fraction of human peripheral blood gamma/delta + T cells is activated by Mycobacterium tuberculosis but not by its 65-kD heat shock protein. J Exp Med (1990) 2.37
Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. Ann Surg (1999) 2.36
Venoocclusive disease of the liver following bone marrow transplantation. Transplantation (1987) 2.35
Differential T cell responses to Mycobacterium tuberculosis ESAT6 in tuberculosis patients and healthy donors. Eur J Immunol (1998) 2.35
Prognostication of neurologic outcome in cardiac arrest patients after mild therapeutic hypothermia: a meta-analysis of the current literature. Intensive Care Med (2013) 2.35
The role of proteases during apoptosis. FASEB J (1996) 2.35
Protective role of gamma/delta T cells and alpha/beta T cells in tuberculosis. Eur J Immunol (1995) 2.34
Transfusion-associated graft-versus-host disease in nonimmunocompromised hosts. Transfusion (1990) 2.33
Choledochal cyst disease. A changing pattern of presentation. Ann Surg (1994) 2.33
Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J Clin Invest (1999) 2.32
Thalidomide for the treatment of chronic graft-versus-host disease. N Engl J Med (1992) 2.31
Lethal tuberculosis in interleukin-6-deficient mutant mice. Infect Immun (1997) 2.31
Cleavage of lamin A by Mch2 alpha but not CPP32: multiple interleukin 1 beta-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis. Proc Natl Acad Sci U S A (1996) 2.31
Comparative proteome analysis of Mycobacterium tuberculosis and Mycobacterium bovis BCG strains: towards functional genomics of microbial pathogens. Mol Microbiol (1999) 2.28
DNA repair and aging in basal cell carcinoma: a molecular epidemiology study. Proc Natl Acad Sci U S A (1993) 2.27
Chemical splanchnicectomy in patients with unresectable pancreatic cancer. A prospective randomized trial. Ann Surg (1993) 2.26
Primary responses of human T cells to mycobacteria: a frequent set of gamma/delta T cells are stimulated by protease-resistant ligands. Eur J Immunol (1990) 2.25
Delivery of antigen-encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogenes. Nat Biotechnol (1998) 2.25
Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg (1999) 2.23
Management of proximal cholangiocarcinomas by surgical resection and radiotherapy. Am J Surg (1990) 2.21
Cyclosporin A binding to calmodulin: a possible site of action on T lymphocytes. Science (1985) 2.17
Caspases and caspase inhibitors. Trends Biochem Sci (1997) 2.17
Complexity of human T-cell antigen receptor beta-chain constant- and variable-region genes. Nature (1985) 2.15
Chest wall constriction after too extensive and too early operations for pectus excavatum. Ann Thorac Surg (1996) 2.12
Dermatitis/nephropathy syndrome of pigs. Vet Rec (1993) 2.11
Angioplasty, bypass surgery, and amputation for lower extremity peripheral arterial disease in Maryland: a closer look. Radiology (1993) 2.10
Interferon-gamma production by Listeria monocytogenes-specific T cells active in cellular antibacterial immunity. Eur J Immunol (1983) 2.06
Lichenoid chronic graft-vs-host disease occurring in a dermatomal distribution. Arch Dermatol (1994) 2.05
Antigen-specific Lyt-2+ cytolytic T lymphocytes from mice infected with the intracellular bacterium Listeria monocytogenes. J Immunol (1986) 2.04
A comparison of five stroke scales with measures of disability, handicap, and quality of life. Stroke (1993) 2.02
Alterations in insulin binding accompanying differentiation of 3T3-L1 preadipocytes. Proc Natl Acad Sci U S A (1977) 2.01
Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine (Baltimore) (1985) 2.01
Considerations in the isolation of rat liver nuclear matrix, nuclear envelope, and pore complex lamina. Exp Cell Res (1981) 1.99
Genetic control of basal serum immunoglobulin E level and its effect on specific reaginic sensitivity. Proc Natl Acad Sci U S A (1974) 1.98
Fungicidal activity of IFN-gamma-activated macrophages. Extracellular killing of Cryptococcus neoformans. J Immunol (1989) 1.97
Acquired resistance to facultative intracellular bacteria: relationship between persistence, cross-reactivity at the T-cell level, and capacity to stimulate cellular immunity of different Listeria strains. Infect Immun (1984) 1.96
Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemia. Leukemia (2006) 1.95
T lymphocytes from healthy individuals with specificity to self-epitopes shared by the mycobacterial and human 65-kilodalton heat shock protein. J Immunol (1989) 1.94
Factors influencing mortality in the treatment of pyogenic hepatic abscess. Surg Gynecol Obstet (1975) 1.91
Perioperative morbidity in patients randomized to epidural or general anesthesia for lower extremity vascular surgery. Perioperative Ischemia Randomized Anesthesia Trial Study Group. Anesthesiology (1993) 1.87
Do preoperative biliary stents increase postpancreaticoduodenectomy complications? J Gastrointest Surg (2000) 1.86